{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:45:55Z","timestamp":1793724355466,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72024-8","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T20:26:23Z","timestamp":1725567983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Simona","family":"D\u2019Aprile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Denaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lavoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Candido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Giallongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Torrisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Salvatorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Amorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Tibullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Libra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesarina","family":"Giallongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzio","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"72024_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12-802997-8.00023-2","volume":"134","author":"HG Wirsching","year":"2016","unstructured":"Wirsching, H. G., Galanis, E. & Weller, M. Glioblastoma. Handb. Clin. Neurol. 134, 381\u2013397. https:\/\/doi.org\/10.1016\/B978-0-12-802997-8.00023-2 (2016).","journal-title":"Handb. Clin. Neurol."},{"key":"72024_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/antiox12020220","volume":"12","author":"F Torrisi","year":"2023","unstructured":"Torrisi, F. et al. Epigenetics and metabolism reprogramming interplay into glioblastoma: Novel insights on immunosuppressive mechanisms. Antioxidants 12, 220. https:\/\/doi.org\/10.3390\/antiox12020220 (2023).","journal-title":"Antioxidants"},{"key":"72024_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen, P. Y. et al. Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 22, 1073\u20131113. https:\/\/doi.org\/10.1093\/neuonc\/noaa106 (2020).","journal-title":"Neuro Oncol."},{"key":"72024_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/cancers14030600","volume":"14","author":"F Fabro","year":"2022","unstructured":"Fabro, F., Lamfers, M. L. M. & Leenstra, S. Advancements, challenges, and future directions in tackling glioblastoma resistance to small kinase inhibitors. Cancers 14, 600. https:\/\/doi.org\/10.3390\/cancers14030600 (2022).","journal-title":"Cancers"},{"key":"72024_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/biomedicines10040806","volume":"10","author":"F Torrisi","year":"2022","unstructured":"Torrisi, F. et al. The hallmarks of glioblastoma: Heterogeneity, intercellular crosstalk and molecular signature of invasiveness and progression. Biomedicines 10, 806. https:\/\/doi.org\/10.3390\/biomedicines10040806 (2022).","journal-title":"Biomedicines"},{"key":"72024_CR6","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1073\/pnas.1219747110","volume":"110","author":"A Sottoriva","year":"2013","unstructured":"Sottoriva, A. et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl. Acad. Sci. U.S.A. 110, 4009\u20134014. https:\/\/doi.org\/10.1073\/pnas.1219747110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"72024_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak, R. G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98\u2013110. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.020 (2010).","journal-title":"Cancer Cell"},{"key":"72024_CR8","doi-asserted-by":"publisher","first-page":"2002015","DOI":"10.1002\/advs.202002015","volume":"7","author":"Z Azam","year":"2020","unstructured":"Azam, Z., To, S. T. & Tannous, B. A. Mesenchymal transformation: The Rosetta stone of glioblastoma pathogenesis and therapy resistance. Adv. Sci. 7, 2002015. https:\/\/doi.org\/10.1002\/advs.202002015 (2020).","journal-title":"Adv. Sci."},{"key":"72024_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","volume":"24","author":"KPL Bhat","year":"2013","unstructured":"Bhat, K. P. L. et al. Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 24, 331\u2013346. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.001 (2013).","journal-title":"Cancer Cell"},{"key":"72024_CR10","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.celrep.2016.11.056","volume":"17","author":"A Segerman","year":"2016","unstructured":"Segerman, A. et al. Clonal variation in drug and radiation response among glioma-initiating cells is linked to proneural-mesenchymal transition. Cell Rep. 17, 2994\u20133009. https:\/\/doi.org\/10.1016\/j.celrep.2016.11.056 (2016).","journal-title":"Cell Rep."},{"key":"72024_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522\u2013526. https:\/\/doi.org\/10.1038\/nature11287 (2012).","journal-title":"Nature"},{"key":"72024_CR12","doi-asserted-by":"publisher","first-page":"1166104","DOI":"10.3389\/fmed.2023.1166104","volume":"10","author":"OD Mowforth","year":"2023","unstructured":"Mowforth, O. D. et al. Personalised therapeutic approaches to glioblastoma: A systematic review. Front. Med. 10, 1166104. https:\/\/doi.org\/10.3389\/fmed.2023.1166104 (2023).","journal-title":"Front. Med."},{"key":"72024_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/biology10080767","volume":"10","author":"F Torrisi","year":"2021","unstructured":"Torrisi, F. et al. Connexin 43 and sonic hedgehog pathway interplay in glioblastoma cell proliferation and migration. Biology 10, 767. https:\/\/doi.org\/10.3390\/biology10080767 (2021).","journal-title":"Biology"},{"key":"72024_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1678921","volume":"8","author":"JD Bernstock","year":"2019","unstructured":"Bernstock, J. D. et al. A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition. Oncoimmunology 8, e1678921. https:\/\/doi.org\/10.1080\/2162402X.2019.1678921 (2019).","journal-title":"Oncoimmunology"},{"key":"72024_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042 (2012).","journal-title":"Cell"},{"key":"72024_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: Mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"72024_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng, J. & Conrad, M. The metabolic underpinnings of ferroptosis. Cell Metab 32, 920\u2013937. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.011 (2020).","journal-title":"Cell Metab"},{"key":"72024_CR18","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/antiox11081596","volume":"11","author":"G Carota","year":"2022","unstructured":"Carota, G. et al. Neuroprotective role of alpha-lipoic acid in iron-overload-mediated toxicity and inflammation in in vitro and in vivo models. Antioxidants 11, 1596. https:\/\/doi.org\/10.3390\/antiox11081596 (2022).","journal-title":"Antioxidants"},{"key":"72024_CR19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191. https:\/\/doi.org\/10.1038\/ncb3064 (2014).","journal-title":"Nat. Cell Biol."},{"key":"72024_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Liu, X., Jin, S., Chen, Y. & Guo, R. Ferroptosis in cancer therapy: A novel approach to reversing drug resistance. Mol. Cancer 21, 47. https:\/\/doi.org\/10.1186\/s12943-022-01530-y (2022).","journal-title":"Mol. Cancer"},{"key":"72024_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei, G., Zhuang, L. & Gan, B. Targeting ferroptosis as a vulnerability in cancer. Nat. Rev. Cancer 22, 381\u2013396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"72024_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang, C., Zhang, X., Yang, M. & Dong, X. Recent progress in ferroptosis inducers for cancer therapy. Adv. Mater. 31, e1904197. https:\/\/doi.org\/10.1002\/adma.201904197 (2019).","journal-title":"Adv. Mater."},{"key":"72024_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0009-8981(00)00219-9","volume":"296","author":"GM Rao","year":"2000","unstructured":"Rao, G. M., Rao, A. V., Raja, A., Rao, S. & Rao, A. Role of antioxidant enzymes in brain tumours. Clin. Chim. Acta 296, 203\u2013212. https:\/\/doi.org\/10.1016\/s0009-8981(00)00219-9 (2000).","journal-title":"Clin. Chim. Acta"},{"key":"72024_CR24","doi-asserted-by":"publisher","first-page":"1068437","DOI":"10.3389\/fmolb.2022.1068437","volume":"9","author":"Q Lu","year":"2022","unstructured":"Lu, Q. et al. Recent advances in ferroptosis and therapeutic strategies for glioblastoma. Front. Mol. Biosci. 9, 1068437. https:\/\/doi.org\/10.3389\/fmolb.2022.1068437 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"72024_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/medicina58020319","volume":"58","author":"AO Mitre","year":"2022","unstructured":"Mitre, A. O. et al. Ferroptosis involvement in glioblastoma treatment. Medicina 58, 319. https:\/\/doi.org\/10.3390\/medicina58020319 (2022).","journal-title":"Medicina"},{"key":"72024_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010 (2014).","journal-title":"Cell"},{"key":"72024_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.974156","volume":"9","author":"S Zhuo","year":"2022","unstructured":"Zhuo, S. et al. Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges. Front. Mol. Biosci. 9, 974156. https:\/\/doi.org\/10.3389\/fmolb.2022.974156 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"72024_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/2326-6066.CIR-20-0384","volume":"9","author":"JM Drijvers","year":"2021","unstructured":"Drijvers, J. M. et al. Pharmacologic screening identifies metabolic vulnerabilities of CD8(+) T cells. Cancer Immunol. Res. 9, 184\u2013199. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0384 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"72024_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov, A. A. et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat. Chem. Biol. 16, 278\u2013290. https:\/\/doi.org\/10.1038\/s41589-019-0462-8 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"72024_CR30","doi-asserted-by":"publisher","first-page":"e13792","DOI":"10.15252\/emmm.202013792","volume":"13","author":"CW Brown","year":"2021","unstructured":"Brown, C. W., Chhoy, P., Mukhopadhyay, D., Karner, E. R. & Mercurio, A. M. Targeting prominin2 transcription to overcome ferroptosis resistance in cancer. EMBO Mol. Med. 13, e13792. https:\/\/doi.org\/10.15252\/emmm.202013792 (2021).","journal-title":"EMBO Mol. Med."},{"key":"72024_CR31","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","volume":"30","author":"H Feng","year":"2020","unstructured":"Feng, H. et al. Transferrin receptor is a specific ferroptosis marker. Cell Rep. 30, 3411-3423.e7. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.049 (2020).","journal-title":"Cell Rep."},{"key":"72024_CR32","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1186\/s12967-023-04664-9","volume":"21","author":"S D'Aprile","year":"2023","unstructured":"D\u2019Aprile, S. et al. Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance. J. Transl. Med. 21, 780. https:\/\/doi.org\/10.1186\/s12967-023-04664-9 (2023).","journal-title":"J. Transl. Med."},{"key":"72024_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13014-023-02241-4","volume":"18","author":"LE Schnoller","year":"2023","unstructured":"Schnoller, L. E. et al. Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data. Radiat. Oncol. 18, 51. https:\/\/doi.org\/10.1186\/s13014-023-02241-4 (2023).","journal-title":"Radiat. Oncol."},{"key":"72024_CR34","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/ijms20081853","volume":"20","author":"BM Fox","year":"2019","unstructured":"Fox, B. M. et al. SUMOylation in glioblastoma: A novel therapeutic target. Int. J. Mol. Sci. 20, 1853. https:\/\/doi.org\/10.3390\/ijms20081853 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"72024_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.871798","volume":"12","author":"L Longhitano","year":"2022","unstructured":"Longhitano, L. et al. Lactate induces the expressions of MCT1 and HCAR1 to promote tumor growth and progression in glioblastoma. Front. Oncol. 12, 871798. https:\/\/doi.org\/10.3389\/fonc.2022.871798 (2022).","journal-title":"Front. Oncol."},{"key":"72024_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/ijms22010351","volume":"22","author":"A Ou","year":"2020","unstructured":"Ou, A., Yung, W. K. A. & Majd, N. Molecular mechanisms of treatment resistance in glioblastoma. Int. J. Mol. Sci. 22, 351. https:\/\/doi.org\/10.3390\/ijms22010351 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"72024_CR37","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3390\/biomedicines11061579","volume":"11","author":"A Roncevic","year":"2023","unstructured":"Roncevic, A. et al. Personalized treatment of glioblastoma: Current state and future perspective. Biomedicines 11, 1579. https:\/\/doi.org\/10.3390\/biomedicines11061579 (2023).","journal-title":"Biomedicines"},{"key":"72024_CR38","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.3390\/cancers14205041","volume":"14","author":"M Gaca-Tabaszewska","year":"2022","unstructured":"Gaca-Tabaszewska, M., Bogusiewicz, J. & Bojko, B. Metabolomic and lipidomic profiling of gliomas\u2014A new direction in personalized therapies. Cancers 14, 5041. https:\/\/doi.org\/10.3390\/cancers14205041 (2022).","journal-title":"Cancers"},{"key":"72024_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-022-03215-3","volume":"72","author":"L Longhitano","year":"2023","unstructured":"Longhitano, L. et al. Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma. Cancer Immunol. Immunother. 72, 1\u201320. https:\/\/doi.org\/10.1007\/s00262-022-03215-3 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"72024_CR40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia, B., Vandenabeele, P. & Vanden Berghe, T. Targeting ferroptosis to iron out cancer. Cancer Cell 35, 830\u2013849. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.002 (2019).","journal-title":"Cancer Cell"},{"key":"72024_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41416-019-0660-x","volume":"122","author":"N Liu","year":"2020","unstructured":"Liu, N., Lin, X. & Huang, C. Activation of the reverse transsulfuration pathway through NRF2\/CBS confers erastin-induced ferroptosis resistance. Br. J. Cancer 122, 279\u2013292. https:\/\/doi.org\/10.1038\/s41416-019-0660-x (2020).","journal-title":"Br. J. Cancer"},{"key":"72024_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2015.1054549","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu, Y. et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol. Cell Oncol. 2, e1054549. https:\/\/doi.org\/10.1080\/23723556.2015.1054549 (2015).","journal-title":"Mol. Cell Oncol."},{"key":"72024_CR43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi, J. et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell 33, 890-904.e5. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.017 (2018).","journal-title":"Cancer Cell"},{"key":"72024_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102006","volume":"43","author":"G Luis","year":"2021","unstructured":"Luis, G. et al. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox. Biol. 43, 102006. https:\/\/doi.org\/10.1016\/j.redox.2021.102006 (2021).","journal-title":"Redox. Biol."},{"key":"72024_CR45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli, J. P., Krysko, D. V. & Conrad, M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat. Rev. Cancer 19, 405\u2013414. https:\/\/doi.org\/10.1038\/s41568-019-0149-1 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"72024_CR46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula, P., Zhuang, L. & Gan, B. Cystine transporter SLC7A11\/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12, 599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5 (2021).","journal-title":"Protein Cell"},{"key":"72024_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang, W. S. & Stockwell, B. R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234\u2013245. https:\/\/doi.org\/10.1016\/j.chembiol.2008.02.010 (2008).","journal-title":"Chem. Biol."},{"key":"72024_CR48","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/biomedicines10040891","volume":"10","author":"K Weaver","year":"2022","unstructured":"Weaver, K. & Skouta, R. The selenoprotein glutathione peroxidase 4: From molecular mechanisms to novel therapeutic opportunities. Biomedicines 10, 891. https:\/\/doi.org\/10.3390\/biomedicines10040891 (2022).","journal-title":"Biomedicines"},{"key":"72024_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101611","volume":"36","author":"G Camiolo","year":"2020","unstructured":"Camiolo, G. et al. Iron regulates myeloma cell\/macrophage interaction and drives resistance to bortezomib. Redox. Biol. 36, 101611. https:\/\/doi.org\/10.1016\/j.redox.2020.101611 (2020).","journal-title":"Redox. Biol."},{"key":"72024_CR50","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.bbadis.2019.05.009","volume":"1865","author":"SK NaveenKumar","year":"2019","unstructured":"NaveenKumar, S. K., Hemshekhar, M., Kemparaju, K. & Girish, K. S. Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: Protection by melatonin. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 2303\u20132316. https:\/\/doi.org\/10.1016\/j.bbadis.2019.05.009 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"72024_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114584","volume":"190","author":"G Xu","year":"2021","unstructured":"Xu, G., Wang, H., Li, X., Huang, R. & Luo, L. Recent progress on targeting ferroptosis for cancer therapy. Biochem. Pharmacol. 190, 114584. https:\/\/doi.org\/10.1016\/j.bcp.2021.114584 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"72024_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/685396","volume":"2014","author":"R Parenti","year":"2014","unstructured":"Parenti, R., Salvatorelli, L. & Magro, G. Anaplastic thyroid carcinoma: Current treatments and potential new therapeutic options with emphasis on TfR1\/CD71. Int. J. Endocrinol. 2014, 685396. https:\/\/doi.org\/10.1155\/2014\/685396 (2014).","journal-title":"Int. J. Endocrinol."},{"key":"72024_CR53","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/thy.2010.0173","volume":"21","author":"G Magro","year":"2011","unstructured":"Magro, G. et al. Aberrant expression of TfR1\/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. Thyroid 21, 267\u2013277. https:\/\/doi.org\/10.1089\/thy.2010.0173 (2011).","journal-title":"Thyroid"},{"key":"72024_CR54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt, T. M., Proneth, B. & Conrad, M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic. Biol. Med. 133, 144\u2013152. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.014 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"72024_CR55","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/cdd.2015.93","volume":"23","author":"M Hayano","year":"2016","unstructured":"Hayano, M., Yang, W. S., Corn, C. K., Pagano, N. C. & Stockwell, B. R. Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ. 23, 270\u2013278. https:\/\/doi.org\/10.1038\/cdd.2015.93 (2016).","journal-title":"Cell Death Differ."},{"key":"72024_CR56","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693\u2013698. https:\/\/doi.org\/10.1038\/s41586-019-1707-0 (2019).","journal-title":"Nature"},{"key":"72024_CR57","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula, M. et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat. Chem. Biol. 16, 1351\u20131360. https:\/\/doi.org\/10.1038\/s41589-020-0613-y (2020).","journal-title":"Nat. Chem. Biol."},{"key":"72024_CR58","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol. Ther. 29, 2185\u20132208. https:\/\/doi.org\/10.1016\/j.ymthe.2021.03.022 (2021).","journal-title":"Mol. Ther."},{"key":"72024_CR59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24010024","volume":"24","author":"L Longhitano","year":"2022","unstructured":"Longhitano, L. et al. Lactate rewrites the metabolic reprogramming of uveal melanoma cells and induces quiescence phenotype. Int. J. Mol. Sci. 24, 24. https:\/\/doi.org\/10.3390\/ijms24010024 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"72024_CR60","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/biomedicines11020474","volume":"11","author":"G Caruso","year":"2023","unstructured":"Caruso, G. et al. Characterization of carnosine effect on human microglial cells under basal conditions. Biomedicines 11, 474. https:\/\/doi.org\/10.3390\/biomedicines11020474 (2023).","journal-title":"Biomedicines"},{"key":"72024_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ab.2003.07.013","volume":"322","author":"G Lazzarino","year":"2003","unstructured":"Lazzarino, G. et al. Single-sample preparation for simultaneous cellular redox and energy state determination. Anal. Biochem. 322, 51\u201359. https:\/\/doi.org\/10.1016\/j.ab.2003.07.013 (2003).","journal-title":"Anal. Biochem."},{"key":"72024_CR62","doi-asserted-by":"publisher","first-page":"9745","DOI":"10.18632\/aging.103241","volume":"12","author":"S Giallongo","year":"2020","unstructured":"Giallongo, S. et al. Loss of macroH2A1 decreases mitochondrial metabolism and reduces the aggressiveness of uveal melanoma cells. Aging 12, 9745\u20139760. https:\/\/doi.org\/10.18632\/aging.103241 (2020).","journal-title":"Aging"},{"key":"72024_CR63","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1126\/sciadv.abd4676","volume":"7","author":"L Xu","year":"2021","unstructured":"Xu, L. et al. Topography of transcriptionally active chromatin in glioblastoma. Sci. Adv. 7, 4676. https:\/\/doi.org\/10.1126\/sciadv.abd4676 (2021).","journal-title":"Sci. Adv."},{"key":"72024_CR64","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrd.2016.248","volume":"16","author":"BJ Crielaard","year":"2017","unstructured":"Crielaard, B. J., Lammers, T. & Rivella, S. Targeting iron metabolism in drug discovery and delivery. Nat. Rev. Drug Discov. 16, 400\u2013423. https:\/\/doi.org\/10.1038\/nrd.2016.248 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"72024_CR65","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346\u2013350. https:\/\/doi.org\/10.1038\/nature10350 (2011).","journal-title":"Nature"},{"key":"72024_CR66","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.tibs.2017.07.002","volume":"42","author":"KA Verba","year":"2017","unstructured":"Verba, K. A. & Agard, D. A. How Hsp90 and Cdc37 Lubricate Kinase Molecular Switches. Trends Biochem. Sci. 42, 799\u2013811. https:\/\/doi.org\/10.1016\/j.tibs.2017.07.002 (2017).","journal-title":"Trends Biochem. Sci."},{"key":"72024_CR67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang, F. et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 35, 84-100.e8. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.021 (2023).","journal-title":"Cell Metab."},{"key":"72024_CR68","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675\u2013678. https:\/\/doi.org\/10.1038\/s41587-020-0546-8 (2020).","journal-title":"Nat. Biotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72024-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T20:29:07Z","timestamp":1725568147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72024-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72024"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72024-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20770"}}